Ultragenyx Pharmaceutical Inc

NASDAQ: RARE
$52.18
+$1.12 (+2.2%)
Closing Price on November 5, 2024

RARE Articles

Monday's top analyst upgrades and downgrades included Accenture, Boeing, CRISPR Therapeutics, DraftKings, Illumina, Lyft, McDonald's, Southwest Airlines and Teladoc Health.
These three biotech stocks have gigantic upside and a fair amount of risk as well. While they are not suited for conservative accounts, the companies all have had very positive data and their shares...
Wednesday's top analyst upgrades, downgrades and initiations included Altice USA, CenturyLink, Cigna, Emerson Electric, Foot Locker, Groupon, Lululemon Athletica, Nike, State Street and Walt Disney.